HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

2- hydroxymethyl- 2- methoxymethylazabicyclo(2.2.2)octan- 3- one

works in tandem with cisplatin to cause apoptosis of tumor cells; structure in first source
Also Known As:
PRIMA-1(MET)
Networked: 10 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Wiman, K G: 4 articles (12/2010 - 02/2007)
2. Selivanova, Galina: 2 articles (05/2011 - 05/2005)
3. Rökaeus, N: 2 articles (12/2010 - 02/2007)
4. Shen, J: 2 articles (12/2010 - 11/2008)
5. Bykov, V J N: 2 articles (12/2010 - 03/2010)
6. Chibon, Frédéric: 1 article (01/2015)
7. Italiano, Antoine: 1 article (01/2015)
8. Neuville, Agnes: 1 article (01/2015)
9. Grellety, Thomas: 1 article (01/2015)
10. Lagarde, Pauline: 1 article (01/2015)

Related Diseases

1. Sarcoma (Soft Tissue Sarcoma)
2. Multiple Myeloma
3. Neoplasms (Cancer)
4. Prostatic Neoplasms (Prostate Cancer)
5. Leukemia

Related Drugs and Biologics

1. Small Interfering RNA (siRNA)
2. Proteins (Proteins, Gene)
3. Doxorubicin (Adriamycin)
4. Dexamethasone (Maxidex)
5. Cisplatin (Platino)
6. 2,2- bis(hydroxymethyl)- 1- azabicyclo(2,2,2,)octan- 3- one

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)